# FDA Inspection 673832 - Octapharma Plasma, Inc. - June 22, 2010

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/d16421c5-c500-4df6-9ec8-e0c588d1f4ce
Source feed: FDA_Inspections

> FDA Inspection 673832 for Octapharma Plasma, Inc. on June 22, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 673832
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2010-06-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1170457 - 2022-05-12](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/6161e8ce-325e-4229-a950-b4115727ebd0)
- [FDA Inspection 1170457 - 2022-05-12](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/0096afc8-cf25-4c2e-b478-95bcf9346373)
- [FDA Inspection 1114211 - 2019-10-24](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/bb429196-cdfe-45a2-a4fb-6bdbabe3e683)
- [FDA Inspection 1041438 - 2018-01-11](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/14a52573-4dc8-416e-90ab-24b2e2cc8670)
- [FDA Inspection 890539 - 2014-08-06](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/fcb1ba80-72fd-4a84-9cc0-ce573bfc97e7)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/e5c7debf-37f7-4418-8c66-c089121fc3a9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d